Skip to main
GRCL
GRCL logo

Gracell Biotechnologies (GRCL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Gracell Biotechnologies (GRCL) Stock

About Gracell Biotechnologies (GRCL)

Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China.
Market cap$983.25M
Today's volume
Revenue (TTM)
Avg. daily volume1.37M
EBITDA (TTM)
Open
Price / earnings ratio-10.08x
Today's range
Debt / equity
52 week range$1.4 - $10.44
5 year debt / equity17.07x
Beta (LTM)1.62x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 13, 2023
Dividend payable date

Gracell Biotechnologies Stock Rating

What analysts recommend for GRCL stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 38%
Buy 13%
Hold 50%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 29, 2025, the market cap for GRCL stock is $983.25M

The current P/E ratio for GRCL stock is -10.08

The 52-week high for GRCL stock is $10.44. The current GRCL stock price $undefined is 100.00% below its 52-week high

The 52-week low for GRCL stock is $1.40. The current GRCL stock price $undefined has increased 100.00% from its 52-week low

No, the GRCL stock does not pay dividends to its shareholders

The target price for GRCL stock is $15.16 based on the average of what a group of analyst think GRCL stock could be worth at a future date. This is not a prediction by Public.com

How to buy GRCL stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in GRCL stock

    Navigate to the Explore page. Then, type GRCL into the search bar. When you see GRCL stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased GRCL stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Gracell Biotechnologies Stock Earnings

The value each GRCL share was expected to gain vs. the value that each GRCL share actually gained.

Gracell Biotechnologies (GRCL) reported Q3 2023 earnings per share (EPS) of -$0.10, beating estimates of -$0.20 by 50.00%. In the same quarter last year, Gracell Biotechnologies's earnings per share (EPS) was -$0.35. Gracell Biotechnologies is expected to release next earnings on 11/13/2023, with an earnings per share (EPS) estimate of $0.

Buy Gracell Biotechnologies (GRCL) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.